세계의 의료기기 상환 시장 : 규모, 점유율 및 동향 분석(청구별, 지불자별, 서비스 제공업체별, 지역별), 부문별 예측(2025-2030년)

Medical Devices Reimbursement Market Growth & Trends:

The global medical devices reimbursement market size is expected to reach USD 1,171.72 billion by 2030, expanding at a CAGR of 7.07% from 2025 to 2030, according to a new report by Grand View Research, Inc. Medical device reimbursement is defined as the payment a third-party private or public insurer pays a healthcare provider for the cost incurred while using medical equipment. The major factors fueling the industry growth are growing dependence on reimbursement, the increasing prevalence of chronic diseases, and growing preventive care. Focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more reimbursement share from them.

For instance, a fundamental paradigm shift towards incentivizing early diagnosis through reimbursement has been noticed across developed economies, such as thorough screening for breast cancer. During the COVID-19 pandemic, surgeries such as robotic-assisted procedures were postponed. However, during the pandemic recovery period, these surgeries are expected to improve particularly in Asia pacific as the countries such as Japan and China are actively involved in providing reimbursement to robotic-assisted providers to improve the accuracy of surgeries. Such initiatives are likely to have a positive impact on market growth in the post-pandemic period. With an increasing demand for medical equipment, reimbursement services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, the increasing number of people pursuing insurance and consolidation of the healthcare system are major factors fueling the industry growth.

North America dominated the market with a revenue share of over 45.71% in 2024 and is expected to maintain its dominance over the forecast period. The rising demand for healthcare equipment and the increasing number of healthcare centers are expected to drive the industry in this region. The growing prevalence of chronic diseases is driving the demand for various healthcare instruments. This is further expected to support the growth of the regional market. Over the years, the Centers for Medicare & Medicaid Services have reduced the reimbursement for diagnostic radiology in the U.S. For instance, in January 2022, a study published in Science Direct stated that, between 2011 - 2021, there was a steady decline in the reimbursement for diagnostic imaging studies. A continuation of this trend by the government agencies is expected to have a negative impact on the regional market growth in the post-pandemic period.

Medical Devices Reimbursement Market Report Highlights:

• The private payer segment is expected to grow at the fastest CAGR over the forecast period owing to the presence of a large number of private players in the market.
• By healthcare setting, the hospitals are expected to grow at the fastest CAGR over the forecast period to recent technological developments and high patient footfall requiring the use of healthcare instruments.
• Asia Pacific is projected to witness rapid growth during the forecast period owing to the rising penetration of insurance services in rural and urban areas.

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Segment Definitions
    • 1.1.1.1 By Claim
    • 1.1.1.2 By Payers
    • 1.1.1.3 By Service Provider
  • 1.1.2 Estimates And Forecast Timeline
• 1.2 Research Methodology
  • 1.2.1 Model Details
    • 1.2.1.1 Medical Devices Reimbursement Market Size Estimation
    • 1.2.1.2 Forecasting Methodology
    • 1.2.1.3 Region- & Country-Based Segment Share Calculation
    • 1.2.1.4 Medical Devices Reimbursement Market: Cagr Calculation
  • 1.2.2 Information Procurement
    • 1.2.2.1 Purchased Database
    • 1.2.2.2 GVR's Internal Database
    • 1.2.2.3 Primary Research
      • 1.2.2.3.1 Details Of The Primary Research
• 1.3 Information Or Data Analysis
  • 1.3.1 Data Analysis Models
• 1.4 Market Formulation & Validation
• 1.5 List Of Secondary Sources
• 1.6 List Of Abbreviations
• 1.7 Objectives
  • 1.7.1 Objective - 1
  • 1.7.2 Objective - 2
  • 1.7.3 Objective - 3

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Outlook
• 2.3 Competitive Landscape

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Increasing Prevalence Of Various Chronic Diseases
    • 3.2.1.2 Growing Adoption Of Value-Based Healthcare Models
    • 3.2.1.3 Regulatory Policies Supporting Reimbursement Expansion
    • 3.2.1.4 Technological Advancements In Medical Devices
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Complex Framework
• 3.3 Business Analysis Tools
  • 3.3.1 Medical Devices Reimbursement - Porter's Five Forces Analysis
  • 3.3.2 Medical Devices Reimbursement - Pestle Analysis

Chapter 4 Medical Devices Reimbursement Market: Claim Estimates & Trend Analysis

• 4.1 Medical Devices Reimbursement Market Claim Segment Dashboard
• 4.2 Claim Movement & Market Share Analysis, 2024 & 2030
• 4.3 Medical Devices Reimbursement Market Size & Forecast And Forecasts, By Claim, 2018-2030 (USD Billion)
• 4.4 Underpaid r
  • 4.4.1 Underpaid Market, 2018 - 2030 (USD Billion)
• 4.5 Full paid r
  • 4.5.1 Full paid Market, 2018 - 2030 (USD Billion)

Chapter 5 Medical Devices Reimbursement Market: Payer Estimates & Trend Analysis

• 5.1 Medical Devices Reimbursement Market Payer Segment Dashboard
• 5.2 Payer Movement & Market Share Analysis, 2024 & 2030
• 5.3 Medical Devices Reimbursement Market Size & Forecast And Forecasts, By Payer, 2018-2030 (USD Billion)
• 5.4 Public
  • 5.4.1 Public Market, 2018 - 2030 (USD Billion)
• 5.4 Private
  • 5.4.1 Private Market, 2018 - 2030 (USD Billion)

Chapter 6 Medical Devices Reimbursement Market: Service Provider Estimates & Trend Analysis

• 6.1 Medical Devices Reimbursement Market: Service Provider Segment Dashboard
• 6.2 Service Provider Movement & Market Share Analysis, 2024 & 2030
• 6.3 Medical Devices Reimbursement Market Size & Forecast And Forecasts, By Service Provider (USD Billion)
• 6.4 Hospitals
  • 6.4.1 Hopspitals Market, 2018 - 2030 (USD Billion)
• 6.5 Physician Offices
  • 6.5.1 Physician Offices Market, 2018 - 2030 (USD Billion)
• 6.6 Diagnostic Laboratories
  • 6.6.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Billion)
• 6.7 Others
  • 6.7.1 Others Market, 2018 - 2030 (USD Billion)

Chapter 7 Medical Devices Reimbursement Market: Regional Analysis

• 7.1 Regional Outlook
• 7.2 North America
  • 7.2.1 North America Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion).
  • 7.2.2 U.S.
    • 7.2.2.1 Key Country Dynamics
    • 7.2.2.2 U.S. Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.2.3 Canada
    • 7.2.3.1 Key Country Dynamics
    • 7.2.3.2 Canada Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.2.4 Mexico
    • 7.2.4.1 Key Country Dynamics
    • 7.2.4.2 Mexico Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
• 7.3 Europe
  • 7.3.1 Europe Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.2 Germany
    • 7.3.2.1 Key Country Dynamics
    • 7.3.2.2 Germany Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.3 Uk
    • 7.3.3.1 Key Country Dynamics
    • 7.3.3.2 Uk Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.4 France
    • 7.3.4.1 Key Country Dynamics
    • 7.3.4.2 France Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.5 Italy
    • 7.3.5.1 Key Country Dynamics
    • 7.3.5.2 Italy Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.6 Spain
    • 7.3.6.1 Key Country Dynamics
    • 7.3.6.2 Spain Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.7 Sweden
    • 7.3.7.1 Key Country Dynamics
    • 7.3.7.2 Sweden Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.8 Norway
    • 7.3.8.1 Key Country Dynamics
    • 7.3.8.2 Norway Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.3.9 Denmark
    • 7.3.9.1 Key Country Dynamics
    • 7.3.9.2 Denmark Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
• 7.4 Asia Pacific
  • 7.4.1 Asia Pacific Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.2 Japan
    • 7.4.2.1 Key Country Dynamics
    • 7.4.2.2 Japan Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion).
  • 7.4.3 China
    • 7.4.3.1 Key Country Dynamics
    • 7.4.3.2 China Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.5 India
    • 7.4.5.1 Key Country Dynamics
    • 7.4.5.2 India Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.6 Australia
    • 7.4.6.1 Key Country Dynamics
    • 7.4.6.2 Australia Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.7 South Korea
    • 7.4.7.1 Key Country Dynamics
    • 7.4.7.2 South Korea Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.4.8 Thailand
    • 7.4.8.1 Key Country Dynamics
    • 7.4.8.2 Thailand Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
• 7.5 Latin America
  • 7.5.1 Latin America Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.5.2 Brazil
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Brazil Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.5.3 Argentina
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Argentina Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
• 7.6 Middle East & Africa
  • 7.6.1 Middle East & Africa Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.6.2 South Africa
    • 7.6.2.1 Key Country Dynamics
    • 7.6.2.2 South Africa Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.6.3 Saudi Arabia
    • 7.6.3.1 Key Country Dynamics
    • 7.6.3.2 Saudi Arabia Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.6.4 UAE
    • 7.6.4.1 Key Country Dynamics
    • 7.6.4.2 Uae Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)
  • 7.6.5 Kuwait
    • 7.6.5.1 Key Country Dynamics
    • 7.6.5.2 Kuwait Medical Devices Reimbursement Market, 2018 - 2030 (USD Billion)

Chapter 8 Competitive Analysis

• 8.1. Company Categorization
• 8.2. Company Market Position Analysis
• 8.3. Strategy Mapping
• 8.4. Company Profiles/Listing
  • 8.4.1. CRA (IQVIA)
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Service Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. WellCare Health Plans, Inc.
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Service Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. BNP Paribas
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Service Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Boston Scientific
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Service Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Humana
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Service Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Cigna Healthcare
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Service Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Anthem Insurance Companies, Inc. (Elevance Health)
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Service Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Abbott Laboratories
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Service Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Ethicon (J & J Medtech)
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Service Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. AdvaMed
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Service Benchmarking
    • 8.4.10.4. Strategic Initiatives